Wells Fargo Upgrades Ovintiv to Overweight, Raises Price Target to $80 Roth Capital Upgrades APA to Buy, Raises Price Target to $38 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results